Stratcans
Web3 Apr 2024 · A narrative review of the evolution of active surveillance since its inception and an overview of its current landscape and challenges is provided. In response to the rising incidence of indolent, low-risk prostate cancer (PCa) due to increased prostate-specific antigen (PSA) screening in the 1990s, active surveillance (AS) emerged as a treatment … Web24 Jan 2024 · We previously proposed a pragmatic three-tier STRATified CANcer Surveillance (STRATCANS) follow-up strategy based on different progression risks from clinic-pathological and imaging features. Objective: To report early outcomes from the implementation of the STRATCANS protocol in our centre.
Stratcans
Did you know?
Web21 Jun 2024 · Patients & Methods: The STRAtified CANcer Surveillance (STRATCANS) model was retested in an AS cohort from a tertiary UK centre . We studied the association between risk group and progression to ⩾CPG3 disease with Cox regression. Six further categorical variables were then fitted with STRATCANS groups using backward selection, … WebApollo Governance and policies How to deposit Repository preservation Repository terms of use Notice and Takedown Repository service level
WebVolume 34 January - December 2016. December 2016, issue 12. November 2016, issue 11. October 2016, issue 10. October 2016, issue 1. Abstracts from the 36th Congress of the Société Internationale d'Urologie, Buenos Aires, Argentina, October 20–23, 2016. This is a supplement. September 2016, issue 9. August 2016, issue 8. WebRisk stratification is the cornerstone for clinical decision making and treatment selection for these men. Current stratification systems are based on a simplistic 3-tiered system to classify patients as low, intermediate, or high risk.
Web12 Jan 2024 · Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance. UroToday Home Recent Abstracts Urologic Oncology Prostate Cancer WebDevelopment and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance. J Clin Med. 2024 Dec 27;12(1):216. doi: 10.3390/jcm12010216. 2. Thankapannair V, Keates A, Barrett T and Gnanapragasam VJ.
Web27 Dec 2024 · CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance Alexander Light 1,2,3, Artitaya Lophatananon 4, Alexandra Keates 2,3, Vineetha Thankappannair 2, Tristan Barrett 5,6,
WebOver 80% of the nearly 1 million men diagnosed with prostate cancer annually worldwide present with localised or locally advanced non-metastatic disease. Risk stratification is the cornerstone for clinical decision making and treatment selection for these men. bontle modiselle baby showerWeb27 Dec 2024 · Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance godey\\u0027s americanized paris fashions 1851Web1 Jun 2024 · While prostate cancer is uncommon in young males, its incidence increases with age, affecting 1 in 43 men aged 50–59; 1 in 16 men aged 60–69; and 1 in 9 men aged >70. The life-time risk of... bontle modiselle baby picturesWeb7 Mar 2024 · In addition to the conventional clinical characteristics such as PSA-kinetics and DRE, imaging with serial prostate MRI has become prevalent in AS follow-up protocols which may aid in personalised risk-based follow-up. While the STRATCANS model incorporates MRI findings at diagnosis, it does not account for radiological changes during follow-up. bontleng police stationWeb27 Dec 2024 · The STRATCANS model could guide discussions and decision making between clinician and patient in deciding personalised AS strategies. Men with lower risk predictions could safely pursue a less-intense surveillance strategy, potentially improving adherence, safety and costs. godey\\u0027s unrivalled colored fashionsWeb11 Jun 2024 · In total, 117/199 (58.7%) patients underwent initial biopsy, including 96 with a positive MRI (Likert/PI-RADS score ≥3) and 21 patients with a negative MRI. A further 12 patients were biopsied during the follow-up period, thus in total 129 (64.8%) patients were biopsied, of which 9 patients were negative on both Likert and PI-RADS scoring. godface godfaceWebSTRATCANS is based on work we have published and presented in 2 cohorts. These are listed below. In essence it stratifies men into 3 different levels of surveillance based on their PSA density, CPG score (see Cambridge Prognostic Group subpage) and MRI findings. bontle riba